Enhancing Immune Checkpoint Inhibitor therapy in Kidney Cancer

Abstract

The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to testdifferent strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Animal Protocol is now ACURO and UTSW approved. Work will start as soon as no cost extension has been approved.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2019
Accession Number
AD1094794

Entities

People

  • Hans-joerg Hammers

Organizations

  • University of Texas Southwestern Medical Center

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cells
  • Department Of Defense
  • Dermatologic Agents
  • Electronic Mail
  • Immunotherapy
  • Information Operations
  • Inhibition
  • Inhibitors
  • Kidney Cancer
  • Kidney Diseases
  • Radiation
  • Therapy

Readers

  • Clinical Trial Research.
  • Immunology and Pathology
  • Oncology (Cancer Research).